Bausch + Lomb Corp. isn’t resting on the laurels of its consumer health eye care products to drive sales after its spinout from its parent firm in 2022. It’s extending the PreserVision AREDS 2 lutein and zeaxanthin supplement line with a mini-softgel using its proprietary OCUSorb formulation made with micronized forms of the ingredients.
More than line extensions, though, are needed for B+L to separate from Bausch Health Companies Inc. enough to shed...







